Document is current
Any future updates will be listed below
-
Authors
Gao, Lixiong
Li, Hongyu
Ye, Zi
Yan, Yuhan
Li, Wen
Xi, Jiafei
Li, Zhaohui
-
Funding
Funding for this research was provided by:
the Innovation and Development Special Fund from Third Medical Center of Chinese PLA General Hospital (2024BJ-03)
the Innovation and Development Special Fund from Third Medical Center of Chinese PLA General Hospital (2024BJ-02)
National Natural Science Foundation of China (82000923)
Natural Science Foundation of Beijing Municipality (L254092)
- License Information
-
More Information
Article History
Received: 27 May 2025
Accepted: 2 February 2026
First Online: 9 February 2026
Declarations
:
: Only commercialized hESC lines WA09 hESCs and hiPSC line hiPSC-B1 were used in this study. Wicell Institute has confirmed that there was initial ethical approval for collection of human cells. WA09 cell line used in this study was obtained from Wicell Institute under a Material Transfer Agreement (07-W096). CellAPY Biotechnology has confirmed that there was initial ethical approval for collection of human cells, and that the donor had signed informed consent. No other human tissue or animal was used in this study.
: Not applicable.
: The authors declare no competing interests.
